Sickle cell disease and ventricular myocardial strain: A systematic review

Nicholas S Whipple1, Vijaya M Joshi2,3, Ronak J Naik2,3

  • 1Division of Pediatric Hematology/Oncology, Department of Pediatrics, Primary Children's Hospital, University of Utah, Salt Lake City, Utah, USA.

Insights

Cardiac abnormalities are common in sickle cell disease (SCD). Ventricular myocardial strain, an early marker of systolic dysfunction, is frequently abnormal in SCD patients compared to controls.

Area of Science:

  • Cardiology
  • Hematology
  • Medical Imaging

Background:

  • Cardiac disease is the leading cause of mortality in sickle cell disease (SCD).
  • Cardiac abnormalities manifest early in childhood and worsen over time in individuals with SCD.
  • Ventricular myocardial strain (right and left) are sensitive indicators of systolic dysfunction, yet their role in SCD remains under-researched.

Purpose of the Study:

  • To systematically identify and review studies assessing ventricular myocardial strain in individuals with SCD.
  • To summarize reported values of ventricular myocardial strain in SCD.
  • To compare these findings against control populations.

Main Methods:

  • A comprehensive literature search was conducted across four major electronic databases: Medline, Embase, Scopus, and Web of Science.
  • Studies were screened for eligibility, with 18 articles and 17 distinct studies meeting the inclusion criteria.
  • Data on ventricular myocardial strain from included studies were extracted and synthesized.

Main Results:

  • The review found that both right and left ventricular myocardial strain are generally abnormal in individuals with SCD when compared to healthy controls.
  • These abnormalities in myocardial strain were observed even in patients with a normal ejection fraction or shortening fraction.
  • The evaluation of myocardial strain in the SCD population has been inconsistent across studies.

Conclusions:

  • Ventricular myocardial strain is frequently impaired in individuals with sickle cell disease, indicating subclinical systolic dysfunction.
  • Myocardial strain assessment should be considered a valuable tool during echocardiography in patients with SCD.
  • Further consistent evaluation of myocardial strain is warranted to better understand and manage cardiac complications in SCD.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
130
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
173
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
193
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
134
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
79
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
174